Reached Agreement With Japanese Government Regarding Investigational Antibody Cocktail (Casirivimab And Imdevimab) For Covid-19
10/05/2021 07:08
May 10 (Reuters) - Chugai Pharmaceutical Co Ltd 4519.T :
* REACHED AGREEMENT WITH JAPANESE GOVERNMENT REGARDING
INVESTIGATIONAL ANTIBODY COCKTAIL (CASIRIVIMAB AND IMDEVIMAB)
FOR COVID-19
* UNDER THIS AGREEMENT, JAPAN GOVERNMENT WILL SECURE
ANTIBODY
COCKTAIL FOR THE YEAR 2021 FOR DOMESTIC SUPPLY IF IT IS APPROVED
BY THE REGULATORY AUTHORITY IN JAPAN
Source text for Eikon: ID:nTSQJ62c74
Further company coverage: 4519.T
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)